← Back to guidelines
Cardiology38 papers

Hereditary cerebral amyloid angiopathy, Dutch type

Last edited: 4/16/2026

Overview

Hereditary cerebral amyloid angiopathy, Dutch type, is a genetic disorder characterized by the deposition of cystatin C-related amyloid in cerebral blood vessels, leading to recurrent cerebral hemorrhages and cognitive decline 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of cystatin C in amyloid deposits via immunohistochemistry 1.
  • Recommended Tests: Cerebrospinal fluid (CSF) analysis showing significantly low cystatin C concentrations 1.
  • Immunoreactivity: Negative for amyloid fibril protein AA, immunoglobulin light chains, and prealbumin 1.
  • CSF Analysis: Normal concentrations of beta 2-microglobulin, albumin, and IgG 1.
  • Isoelectric Focusing: CSF cystatin C isoelectric point matches normal individuals 1.
  • Management

  • No Specific Drug Treatments Mentioned: Current evidence does not specify first-line or adjunctive pharmacological treatments 1.
  • Supportive Care: Focus on managing symptoms, preventing secondary complications, and supportive neurological care 1.
  • Special Populations

  • No Specific Data Provided: Abstracts do not cover pregnancy, pediatrics, elderly, or comorbidities specifically 1.
  • Key Recommendations

  • Utilize immunohistochemistry to confirm cystatin C deposition in suspected cases (Evidence: Moderate) 1.
  • Evaluate CSF cystatin C levels for diagnostic purposes, noting significantly low levels in affected individuals (Evidence: Moderate) 1.
  • Consider supportive neurological management strategies due to lack of specific pharmacological treatments (Evidence: Expert opinion) 1.
  • References

    1 Löfberg H, Grubb AO, Nilsson EK, Jensson O, Gudmundsson G, Blöndal H et al.. Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 1987. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG